Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies
Authors
Keywords
HIV-1, T cells, Outgrowth assay, Polymerase chain reaction, Highly-active antiretroviral therapy, Viremia, Viral replication, Alu elements
Journal
PLoS Pathogens
Volume 9, Issue 2, Pages e1003174
Publisher
Public Library of Science (PLoS)
Online
2013-02-15
DOI
10.1371/journal.ppat.1003174
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards
- (2012) John M. Murray et al. AIDS
- Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trials
- (2012) Angela M. Mexas et al. AIDS
- Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
- (2012) N. M. Archin et al. NATURE
- Relationship Between Residual Plasma Viremia and the Size of HIV Proviral DNA Reservoirs in Infected Individuals Receiving Effective Antiretroviral Therapy
- (2011) Tae-Wook Chun et al. JOURNAL OF INFECTIOUS DISEASES
- Disulfiram Reactivates Latent HIV-1 in a Bcl-2-Transduced Primary CD4+ T Cell Model without Inducing Global T Cell Activation
- (2011) S. Xing et al. JOURNAL OF VIROLOGY
- Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule
- (2011) L. Josefsson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Elite Suppressors Harbor Low Levels of Integrated HIV DNA and High Levels of 2-LTR Circular HIV DNA Compared to HIV+ Patients On and Off HAART
- (2011) Erin H. Graf et al. PLoS Pathogens
- Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication
- (2010) Tae-Wook Chun et al. AIDS
- Short‐Course Raltegravir Intensification Does Not Reduce Persistent Low‐Level Viremia in Patients with HIV‐1 Suppression during Receipt of Combination Antiretroviral Therapy
- (2010) D. McMahon et al. CLINICAL INFECTIOUS DISEASES
- Differences in HIV Burden and Immune Activation within the Gut of HIV‐Positive Patients Receiving Suppressive Antiretroviral Therapy
- (2010) Steven A. Yukl et al. JOURNAL OF INFECTIOUS DISEASES
- HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
- (2010) Maria J Buzón et al. NATURE MEDICINE
- The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
- (2010) Rajesh T. Gandhi et al. PLOS MEDICINE
- Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid
- (2009) Nancie M. Archin et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Suberoylanilide Hydroxamic Acid Reactivates HIV from Latently Infected Cells
- (2009) Xavier Contreras et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- No Evidence for Decay of the Latent Reservoir in HIV‐1–Infected Patients Receiving Intensive Enfuvirtide‐Containing Antiretroviral Therapy
- (2009) Rajesh T. Gandhi et al. JOURNAL OF INFECTIOUS DISEASES
- Analysis of Human Immunodeficiency Virus Type 1 Viremia and Provirus in Resting CD4+ T Cells Reveals a Novel Source of Residual Viremia in Patients on Antiretroviral Therapy
- (2009) T. P. Brennan et al. JOURNAL OF VIROLOGY
- Detecting HIV-1 integration by repetitive-sampling Alu-gag PCR
- (2009) Megan K. Liszewski et al. METHODS
- Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy
- (2009) J. B. Dinoso et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Challenge of Finding a Cure for HIV Infection
- (2009) D. D. Richman et al. SCIENCE
- CpG Methylation Controls Reactivation of HIV from Latency
- (2009) Jana Blazkova et al. PLoS Pathogens
- Epigenetic Regulation of HIV-1 Latency by Cytosine Methylation
- (2009) Steven E. Kauder et al. PLoS Pathogens
- Orientation-Dependent Regulation of Integrated HIV-1 Expression by Host Gene Transcriptional Readthrough
- (2008) Yefei Han et al. Cell Host & Microbe
- Transcriptional Interference Antagonizes Proviral Gene Expression to Promote HIV Latency
- (2008) Tina Lenasi et al. Cell Host & Microbe
- Persistence of HIV in Gut‐Associated Lymphoid Tissue despite Long‐Term Antiretroviral Therapy
- (2008) Tae‐Wook Chun et al. JOURNAL OF INFECTIOUS DISEASES
- Low-level plasma HIVs in patients on prolonged suppressive highly active antiretroviral therapy are produced mostly by cells other than CD4 T-cells
- (2008) Gautam K. Sahu et al. JOURNAL OF MEDICAL VIROLOGY
- Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
- (2008) S. Palmer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HIV rebounds from latently infected cells, rather than from continuing low-level replication
- (2008) B. Joos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A more precise HIV integration assay designed to detect small differences finds lower levels of integrated DNA in HAART treated patients
- (2008) Jianqing J. Yu et al. VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now